Conversion lung transplant patients from Prograf to Advagraf or Envarsus

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2022
INTERVENTION: tacrolimus: dose administered 1 mg once daily the total duration of administration 3 years the mode of administration tablet prolonged release formulation (Advagraf, Envarsus) CONDITION: for patient with lung transplantation; ; for patient with lung transplantation Respiratory ‐ Other respiratory disorders / diseases PRIMARY OUTCOME: lung function assessed using spirometry. Spirometer; [1 year post transplant] pharmacokinetics parameters of tacrolimus: AUC Cmax, Tmax. Assesed plasma level; [blood samples taken at 24 hours post dose] SECONDARY OUTCOME: compliance questionnaire (The Basel Assessment of adherence to immunosupressive medication scale)[3 years post‐transplant] INCLUSION CRITERIA: minimum age 18 years, 30 days after lung transplant, need to be prescribed tacrolimus (Advagraf, Envarsus) once daily for 30 days after lung transplant
Epistemonikos ID: 6e7e2f08a371f14cc1fc98aba65f35178740e0ae
First added on: Aug 25, 2024